Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

HealWELL AI Inc.

Healthcare CA AIDX

0.81CAD
-0.03(3.57%)

Last update at 2026-06-12T19:46:00Z

Day Range

0.810.84
LowHigh

52 Week Range

0.581.66
LowHigh

Fundamentals

  • Previous Close 0.84
  • Market Cap291.71M
  • Volume149046
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-20.59000M
  • Revenue TTM103.80M
  • Revenue Per Share TTM0.41
  • Gross Profit TTM 57.29M
  • Diluted EPS TTM-0.15

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -39.78000M -28.28200M -32.68300M -17.07600M -16.28800M
Minority interest 0.55M 1.19M - - -
Net income -46.93700M -26.29300M -32.19300M -21.08500M -15.67000M
Selling general administrative 53.49M 42.69M 9.06M 11.36M 30.18M
Selling and marketing expenses - 2.38M 1.28M 1.52M 1.11M
Gross profit 40.39M 17.32M 1.26M 3.71M 15.01M
Reconciled depreciation 16.91M 7.30M - - -
Ebit -29.52600M -25.71500M -17.59200M -17.54800M -16.43400M
Ebitda -12.62100M -18.41800M -16.11300M -15.00800M -12.12500M
Depreciation and amortization 16.91M 7.30M 1.48M 2.54M 4.31M
Non operating income net other - - - - -
Operating income -29.52600M -33.55500M -17.59200M -17.54800M -16.43400M
Other operating expenses 133.33M 72.53M 38.66M 27.74M 64.26M
Interest expense 10.16M 2.61M - 0.62M 0.46M
Tax provision -0.66200M -0.85600M - 1.22M -0.74700M
Interest income - 0.64M - 1.03M 0.35M
Net interest income -9.59100M -1.97200M - - -
Extraordinary items - -0.05400M - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -0.66200M -0.85600M 0.54M 1.12M -0.74700M
Total revenue 103.80M 38.97M 7.32M 10.42M 47.82M
Total operating expenses 69.91M 50.87M 32.60M 21.03M 31.45M
Cost of revenue 63.42M 21.66M 6.06M 6.71M 32.81M
Total other income expense net -10.25400M 5.27M -15.09100M 0.88M 0.64M
Discontinued operations - - - - -
Net income from continuing ops -39.11800M -27.42600M - - -
Net income applicable to common shares - -26.29300M - -21.08500M -15.67000M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 284.99M 125.53M 53.70M 45.63M 60.89M
Intangible assets 106.92M 28.30M 12.51M 11.25M 12.45M
Earning assets - - - - -
Other current assets 6.80M 2.35M 2.35M 1.17M 2.50M
Total liab 161.04M 51.86M 32.23M 33.85M 32.86M
Total stockholder equity 123.94M 63.89M 12.65M 11.78M 28.03M
Deferred long term liab - - - - -
Other current liab 14.76M 13.43M 4.82M - -
Common stock 250.43M 140.08M 67.37M 39.79M 39.79M
Capital stock 250.43M 140.08M - - -
Retained earnings -151.94600M -95.21800M -69.24900M -37.65200M -16.56700M
Other liab - - - - -
Good will 98.55M 67.14M 12.30M 10.07M 10.07M
Other assets - - - 0.47M 1.95M
Cash 18.63M 9.41M 19.16M 1.41M 7.14M
Cash and equivalents - - - - -
Total current liabilities 70.77M 23.32M 9.42M 19.39M 14.49M
Current deferred revenue 15.29M 2.45M - - -
Net debt 67.49M 12.79M 0.76M - -
Short term debt 26.38M 2.73M 0.67M 7.00M 0.00000M
Short long term debt 24.10M 1.78M - - -
Short long term debt total 86.13M 22.20M 19.92M - -
Other stockholder equity - 19.02M 12.57M - -
Property plant equipment - - - 10.44M 13.93M
Total current assets 64.67M 18.33M 22.76M 8.61M 16.51M
Long term investments 8.31M 4.48M - - -
Net tangible assets - - - - -
Short term investments 0.00000M 0.27M - 0.39M 0.54M
Net receivables 39.23M 6.29M 1.24M 4.29M 3.22M
Long term debt 56.37M 14.24M - - -
Inventory - - - - -
Accounts payable 14.34M 4.33M 3.93M - -
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 25.46M -0.00300M 1.96M - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.71M 2.37M 1.99M - -
Deferred long term asset charges - - - - -
Non current assets total 220.31M 107.21M 30.94M - -
Capital lease obligations 5.67M 6.18M - - -
Long term debt total - - - 9.33M 11.26M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments 0.00000M -15.37300M - - -
Change to liabilities - - - - -
Total cashflows from investing activities -69.84300M -15.37300M - -1.16800M -8.64400M
Net borrowings 71.27M - - - -
Total cash from financing activities 95.50M 28.24M 27.20M 3.78M 21.99M
Change to operating activities - - - - -
Net income -38.56500M -27.48000M -31.59700M -20.97000M -15.54100M
Change in cash 9.22M -9.74900M 17.75M -5.73100M 6.25M
Begin period cash flow 9.41M 19.16M 1.41M 7.14M 0.89M
End period cash flow 18.63M 9.41M 19.16M 1.41M 7.14M
Total cash from operating activities -19.42000M -22.61900M -10.79800M -8.34600M -7.09800M
Issuance of capital stock 23.59M 19.12M - - -
Depreciation 16.91M 7.30M 2.80M 2.54M 4.31M
Other cashflows from investing activities -0.91900M -1.22100M - 0.00000M -6.27600M
Dividends paid 0.00000M - - 0.12M 0.00000M
Change to inventory - - - - -
Change to account receivables 1.99M 1.41M 4.51M 0.69M -1.50400M
Sale purchase of stock - -0.62500M - 0.00000M -0.87000M
Other cashflows from financing activities -2.12500M 10.14M 27.60M -0.11600M -1.38100M
Change to netincome - - - - -
Capital expenditures 0.74M 1.31M 0.07M 1.15M 2.37M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -17.17500M -2.83200M 4.56M 2.21M -1.64800M
Stock based compensation 12.99M 7.14M 3.26M 4.83M 6.11M
Other non cash items 20.08M -5.53200M 10.18M -1.13600M -0.23100M
Free cash flow -20.15700M -23.93100M -10.86400M -9.49400M -9.46600M

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
AIDX
HealWELL AI Inc.		 -0.03 3.57% 0.81 - - 2.81 2.35 3.46 -4.9271
EXE
Extendicare Inc		 -0.15 0.46% 32.68 25.21 23.92 1.59 7.26 1.62 14.43
SIA
Sienna Senior Living Inc		 0.02 0.09% 21.47 45.94 38.17 2.23 3.17 3.57 21.90
WELL
WELL Health Technologies Corp		 0.01 0.22% 4.55 - 13.87 0.80 1.23 1.09 9.83
DR
Medical Facilities Corporation		 0.22 1.23% 18.15 15.57 12.94 1.18 2.87 0.92 3.64

Reports Covered

Stock Research & News

View All

Profile

Healwell AI Inc. operates as a healthcare technology company in Canada, Australia, and New Zealand. The company operates in two segments, AI and Data Sciences, and Healthcare Software. It focuses on developing and commercializing clinical decision support systems to help healthcare providers detect rare and chronic diseases. The company provides healthcare artificial intelligence engines, electronic health record platform, healthcare data management and interoperability software, and early/late phase contract clinical research services. It also offers rare and chronic disease screening, real world evidence clinical study generation, advanced clinical decision support, and physical ASI co-pilot tools. It serves public sector organizations, healthcare providers, insurers, and life science companies. The company was formerly known as MCI Onehealth Technologies Inc. and changed its name to Healwell AI Inc. in September 2023. Healwell AI Inc. was incorporated in 2012 and is headquartered in Toronto, Canada.

HealWELL AI Inc.

460 College Street, Toronto, ON, Canada, M6G 1A1

Key Executives

Name Title Year Born
Mr. Donald Watts President of Khure Health NA
Dr. Alexander Julian Dobranowski Founder, CEO, MD & Director NA
Ms. Madeline D. Walker President of MCI Medical 1947
Mr. Anthony Lam Chief Financial Officer NA
Paulo Gomes Co-Chief Operating Officer NA
Adam Hutton Co-Chief Operating Officer NA
Nolan Reeds Vice President of Marketing & Communications NA
Mr. Blake Corbet Senior Vice President of Corporate Development NA
Mr. Mark Findlay Senior Vice President of Sales & Marketing for Canada NA
Aaron Leibtag Pentavere Research Group -CEO NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.